609 related articles for article (PubMed ID: 18724391)
21. Recent advances in the management of nausea and vomiting caused by antineoplastic agents.
Merrifield KR; Chaffee BJ
Clin Pharm; 1989 Mar; 8(3):187-99. PubMed ID: 2650957
[TBL] [Abstract][Full Text] [Related]
22. Management of highly emetogenic chemotherapy.
Warr D
Curr Opin Oncol; 2012 Jul; 24(4):371-5. PubMed ID: 22476193
[TBL] [Abstract][Full Text] [Related]
23. 5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?
Aapro M; Blower P
Cancer; 2005 Jul; 104(1):1-18. PubMed ID: 15929119
[TBL] [Abstract][Full Text] [Related]
24. Anti-emetic therapy in cancer chemotherapy: current status.
Herrstedt J; Dombernowsky P
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
[TBL] [Abstract][Full Text] [Related]
25. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
de Wit R; Aapro M; Blower PR
Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
[TBL] [Abstract][Full Text] [Related]
26. [Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting].
Durand JP; Madelaine I; Scotté F
Bull Cancer; 2009 Oct; 96(10):951-60. PubMed ID: 19734117
[TBL] [Abstract][Full Text] [Related]
27. Aprepitant--where do we stand in the control of chemotherapy-induced nausea and vomiting?
Sarcev T; Secen N; Zaric B; Milovancev A
J BUON; 2008; 13(3):333-9. PubMed ID: 18979546
[TBL] [Abstract][Full Text] [Related]
28. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
[TBL] [Abstract][Full Text] [Related]
29. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
Herrstedt J
Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study.
López-Jiménez J; Martín-Ballesteros E; Sureda A; Uralburu C; Lorenzo I; del Campo R; Fernández C; Calbacho M; García-Belmonte D; Fernández G
Haematologica; 2006 Jan; 91(1):84-91. PubMed ID: 16434375
[TBL] [Abstract][Full Text] [Related]
31. Optimizing antiemetic therapy in multiple-day and multiple cycles of chemotherapy.
Ellebaek E; Herrstedt J
Curr Opin Support Palliat Care; 2008 Mar; 2(1):28-34. PubMed ID: 18685391
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy-induced nausea and vomiting.
Lohr L
Cancer J; 2008; 14(2):85-93. PubMed ID: 18391612
[TBL] [Abstract][Full Text] [Related]
33. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
Jordan K; Sippel C; Schmoll HJ
Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of aprepitant in management of chemotherapy-induced nausea and vomiting.
Osorio-Sanchez JA; Karapetis C; Koczwara B
Intern Med J; 2007 Apr; 37(4):247-50. PubMed ID: 17388865
[TBL] [Abstract][Full Text] [Related]
35. Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence?
Antonarakis ES; Evans JL; Heard GF; Noonan LM; Pizer BL; Hain RD
Pediatr Blood Cancer; 2004 Nov; 43(6):651-8. PubMed ID: 15390297
[TBL] [Abstract][Full Text] [Related]
36. Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: comparison between elderly and non-elderly patient response.
Massa E; Astara G; Madeddu C; Dessì M; Loi C; Lepori S; Mantovani G
Crit Rev Oncol Hematol; 2009 Apr; 70(1):83-91. PubMed ID: 18723369
[TBL] [Abstract][Full Text] [Related]
37. [Nausea and vomiting during treatment with cytostatics].
Kaasa S; Mella O; Kvikstad A
Tidsskr Nor Laegeforen; 1991 Mar; 111(8):941-4. PubMed ID: 2042209
[TBL] [Abstract][Full Text] [Related]
38. Relieving nausea and vomiting in patients with cancer: a treatment algorithm.
Johnson MH; Moroney CE; Gay CF
Oncol Nurs Forum; 1997; 24(1):51-7. PubMed ID: 9007907
[TBL] [Abstract][Full Text] [Related]
39. Nausea: the neglected symptom?
Foubert J; Vaessen G
Eur J Oncol Nurs; 2005 Mar; 9(1):21-32. PubMed ID: 15774338
[TBL] [Abstract][Full Text] [Related]
40. Nausea and vomiting in advanced cancer.
Ang SK; Shoemaker LK; Davis MP
Am J Hosp Palliat Care; 2010 May; 27(3):219-25. PubMed ID: 20197557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]